Acute meningitidis, acute phase proteins and procalcitonin;Les méningites aiguës, protéines inflammatoires et procalcitonine

Annales de Biologie Clinique

Volumn 61, Issue 2, 2003, Pages 127-137

  Mary, R ^a   Veinberg, F ^b   Couderc, R ^b  

^a DELAFONTAINE HOSPITAL   (France)

^b Service de Biochimie   (France)

Author keywords

Diagnosis; Meningitis; Procalcitonin

Indexed keywords

ACUTE PHASE PROTEIN; ANTIINFECTIVE AGENT; C REACTIVE PROTEIN; CALCITONIN; PROCALCITONIN; PROTEIN PRECURSOR; SERUM AMYLOID A;

ACUTE DISEASE; ADULT; BACTERIAL MENINGITIS; BLOOD; CEREBROSPINAL FLUID; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; HUMAN; MENINGITIS; META ANALYSIS; REVIEW; SENSITIVITY AND SPECIFICITY; TIME; VIRUS MENINGITIS;

ACUTE DISEASE; ACUTE-PHASE PROTEINS; ADULT; ANTI-BACTERIAL AGENTS; C-REACTIVE PROTEIN; CALCITONIN; CHILD; CLINICAL TRIALS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MENINGITIS; MENINGITIS, BACTERIAL; MENINGITIS, VIRAL; META-ANALYSIS; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY; SERUM AMYLOID A PROTEIN; TIME FACTORS;

BACTERIA (MICROORGANISMS);

EID: 0242499947     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Quagliarello VJ, Scheld WM. Treatment of bacterial meningitis. N Engl J Med 1997; 336: 708-716.
2. Jaeger F, Leroy J, Duchene F, et al. Validation of a diagnosis model for differentiating bacterial from viral meningitis in infants and children under 3.5 years of age. Eur J Clin Microbiol Infect Dis 2000; 19: 418-21.
3. Gendrel D, Bohuon C. Procalcitonin, a marker of bacterial infection. Infection 1997; 25: 133-4.
4. Gendrel D, Raymond J, Assicot M, et al. Procalcitonine, protéine C-réactive et interleukine 6 dans les méningites bactériennes et virales de l'enfant. Presse Med 1998; 27: 1135-9.
5. Viallon A, Zeni F, Lambert C, et al. High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis. Clin Infect Dis 1999; 28: 1313-6.
6. Viallon A, Pouzet V, Zeni F, et al. Diagnostic rapide du type de méningite (bactérienne ou virale) par le dosage de la procalcitonine sérique. Presse Med 2000; 29: 584-8.
7. Fitoussi F, Mariani-Kurkdjian P. Diagnostic bactériologique et suivi biologique des méningites bactériennes. In: Bingen E, ed. Paris: Elsevier, 2001: 69-80.
8. e édition. Montmorency: 2M2 2002: 254.
9. Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med 1997; 337: 970-6.
10. Rotbart HA. Viral meningitis. Semin Neurol 2000; 20: 277-92.
11. Berlin LE, Rorabaugh ML, Heldrich F, Roberts K, Doran T, Modlin JF. Aseptic meningitis in infants <2 years of age: diagnosis and etiology. J Infect Dis 1993; 168: 888-92.
12. Sawyer MH, Holland D, Aintablian N, Connor JD, Keyser EF, Waecker NJ Jr. Diagnosis of enteroviral central nervous system infection by polymerase chain reaction during a large community outbreak. Pediatr Infect Dis J 1994; 13: 177-82.
13. Dagan R. Nonpolio enteroviruses and the febrile young infant: epidemiologic, clinical and diagnostic aspects. Pediatr Infect Dis J 1996; 15: 67-71.
14. Bricout F, Grimprel E. Guide de Virologie Médicale. Paris: Ellipse/Ed. Marketing 1998: 46.
15. Chambon M, Archimbaud C, Bailly JL, et al. Circulation of enteroviruses and persistence of meningitis cases in the winter of 1999-2000. J Med Virol 2001; 65: 340-7.
16. Hasbun R, Abrahams J, Jekel J, Quagliarello VJ. Computed tomography of the head before lumbar puncture in adults with suspected meningitis. N Engl J Med 2001; 345: 1727-33.
17. Steigbigel NH. Computed tomography of the head before a lumbar puncture in suspected meningitis-is it helpful? N Engl J Med 2001; 345: 1768-70.
18. Wong M, Schlaggar BL, Buller RS, Storch GA, Landt M, Cerebrospinal fluid protein concentration in pediatric patients: defining clinically relevant reference values. Arch Pediatr Adolesc Med 2000; 154: 827-31.
19. Roos KL. Mycobacterium tuberculosis meningitis and other etiologies of the aseptic meningitis syndrome. Semin Neurol 2000; 20: 329-35.
20. Gottfredsson M, Perfect JR. Fungal meningitis. Semin Neurol 2000; 20: 307-22.
21. Bartt R. Listeria and atypical presentations of Listeria in the central nervous system. Semin Neurol 2000; 20: 361-73.
22. Ramers C, Billman G, Hartin M, Ho S, Sawyer MH. Impact of a diagnostic cerebrospinal fluid enterovirus polymerase chain reaction test on patient management. JAMA 2000; 283: 2680-5.
23. Levitz RE. Herpes simplex encephalitis: a review. Heart Lung 1998; 27: 209-12.
24. Sene D, Bossi P, Zeller V, Caumes E, Bricaire F. Méningite virale aiguë: caractéristiques épidémiologiques, cliniques et biologiques de 29 patients hospitalisés. Presse Med 2002; 31: 254-8.
25. Margall Coscojuela N, Majo Moreno M, Latorre Otin C, Fontanals Amyerich D, Dominguez Garcia A, Prats Pastor G. Use of universal PCR on cerebrospinal fluid to diagnose bacterial meningitis in culture-negative patients. Eur J Clin Microbiol Infect Dis 2002; 21: 67-9.
26. Wattre P. La biologie moléculaire au service de la virologie quotidienne. 1. Principes méthodologiques. Ann Biol Clin 1997; 55: 25-31.
27. Read SJ, Jeffery KJ, Bangham CR. Aseptic meningitis and encephalitis: the role of PCR in the diagnostic laboratory. J Clin Microbiol 1997; 35: 691-6.
28. Stellrecht KA, Harding I, Hussain FM, et al. A one-step RT-PCR assay using an enzyme-linked detection system for the diagnosis of enterovirus meningitis. J Clin Virol 2000; 17: 143-9.
29. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-54.
30. Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994; 15: 81-8.
31. Volanakis JE. Human C-reactive protein: expression, structure, and function. Mol Immunol 2001; 38: 189-97.
32. Gerdes LU, Jorgensen PE, Nexo E, Wang P. C-reactive protein and bacterial meningitis: a meta-analysis. Scand J Clin Lab Invest 1998; 58: 383-93.
33. Le Moullec JM, Jullienne A, Chenais J, et al. The complete sequence of human preprocalcitonin. FEBS Lett 1984; 167: 93-7.
34. Russwurm S, Wiederhold M, Oberhoffer M, Stonans I, Zipfel PF, Reinhart K. Molecular aspects and natural source of procalcitonin. Clin Chem Lab Med 1999; 37: 789-97.
35. Cate CC, Pettengill OS, Sorenson GD. Biosynthesis of procalcitonin in small cell carcinoma of the lung. Cancer Res 1986; 46: 812-8.
36. Ghillani PP, Motte P, Troalen F, et al. Identification and measurement of calcitonin precursors in serum of patients with malignant diseases. Cancer Res 1989; 49: 6845-51.
37. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993; 341: 515-8.
38. Al-Nawas B, Shah PM. Procalcitonin, a new diagnostic and prognostic marker for severe infections. Clin Microbiol Infect 1998; 4: 237-41.
39. Bohuon C, Gendrel D. La procalcitonine: nouvel indicateur d'infection bactérienne. Intérêt et perspectives. Arch Pediatr 1999; 6: 141-4.
40. Ferriere F. Intérêt de la procalcitonine, nouveau marqueur de l'infection bactérienne. Ann Biol Clin 2000; 58: 49-59.
41. Reinhart K, Karzai W, Meisner M. Procalcitonin as a marker of the systemic inflammatory response to infection. Intensive Care Med 2000; 26: 1193-200.
42. Whicher J, Bienvenu J, Monneret G. Procalcitonin as an acute phase marker. Ann Clin Biochem 2001; 38: 483-93.
43. Guven H, Altintop L, Baydin A, et al. Diagnostic value of procalcitonin levels as an early indicator of sepsis. Am J Emerg Med 2002; 20: 202-6.
44. Meisner M. Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta 2002; 323: 17-29.
45. Bracq S, Machairas M, Clement B, et al. Calcitonin gene expression in normal human liver. FEBS Lett 1993; 331: 15-8.
46. Nijsten MW, Olinga P, The TH, et al. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 2000; 28: 458-61.
47. Russwurm S, Stonans I, Stonane E, et al. Procalcitonin and CGRP-1 mrna expression in various human tissues. Shock 2001; 16: 109-12.
48. Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994; 79: 1605-8.
49. Brunkhorst FM, Heinz U, Forycki ZF. Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med 1998; 24: 888-9.
50. Gendrel D, Raymond J, Assicot M, et al. Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin Infect Dis 1997; 24: 1240-2.
51. Morin V, Morin JF, Mercier M, Moineau MP, Cadet JP. Les courbes ROC en biologie médicale. Immunoanal Biol Spec 1998; 13: 279-86.
52. Hatherill M, Tibby SM, Sykes K, Turner C, Murdoch IA. Diagnostic markers of infection: comparison of procalcitonin with C reactive protein and leucocyte count. Arch Dis Child 1999; 81: 417-21.
53. Karzai W, Oberhoffer M, Meier-Hellmann A, Reinhart K. Procalcitonin-a new indicator of the systemic response to severe infections. Infection 1997; 25: 329-34.
54. Karzai W, Reinhart K. Sepsis: definitions and diagnosis. Int J Clin Pract Suppl 1998; 95: 44-8.
55. Korczowski B, Bijos A, Rybak A. Procalcitonin in diagnosis of purulent and aseptic meningitis in children. Pol Merkuriusz Lek 2000; 9: 755-7.
56. Schwarz S, Bertram M, Schwab S, Andrassy K, Hacke W. Serum procalcitonin levels in bacterial and abacterial meningitis. Crit Care Med 2000; 28: 1828-32.
57. Hoffmann O, Reuter U, Masuhr F, Holtkamp M, Kassim N, Weber JR. Low sensitivity of serum procalcitonin in bacterial meningitis in adults. Scand J Infect Dis 2001; 33: 215-8.
58. Jereb M, Muzlovic I, Hojker S, Strle F. Predictive value of serum and cerebrospinal fluid procalcitonin levels for the diagnosis of bacterial meningitis. Infection 2001; 29: 209-12.
59. Dumpis U, Crook D, Oksi J. Tick-borne encephalitis. Clin Infect Dis 1999; 28: 882-90.
60. Shimetani N, Shimetani K, Mori M. Levels of three inflammation markers, C-reactive protein, serum amyloid A protein and procalcitonin, in the serum and cerebrospinal fluid of patients with meningitis. Scand J Clin Lab Invest 2001; 61: 567-74.
61. Walport MJ. Complement. First of two parts. N Engl J Med 2001; 344: 1058-66.
62. Speth C, Dierich MP, Gasque P. Neuroinvasion by pathogens: a key role of the complement system. Mol Immunol 2002; 38: 669-79.
63. Unkmeir A, Kammerer U, Stade A, et al. Lipooligosaccharide and polysaccharide capsule: virulence factors of Neisseria meningitidis that determine meningococcal interaction with human dendritic cells. Infect Immun 2002; 70: 2454-62.
64. Marc E, Menager C, Moulin F, et al. Procalcitonine et méningites virales: réduction des traitements antibiotiques inutiles par le dosage en routine au cours d'une épidémie. Arch Pediatr 2002; 9: 358-64.
65. Gendrel D, Bohuon C. Procalcitonin as a marker of bacterial infection. Pediatr Infect Dis J 2000; 19: 679-87; quiz 688.